A patient's quality of life, mortality, and morbidity are all impacted by drug-related problems. These problems can occur at any stage of the prescription, transcription, distribution, and administration of medications. Research into the frequency, manifestations, patterns, and treatment implications of drug-related problems in cardiovascular patients will advance, leading to a rise in patient safety and recovery.Methods: A potential interventional trial was discussed over the course of 8 months in the cardiology and tertiary care medical departments. The required demographic and clinker data were acquired from the case files.Results: In this study, 246 cardiovascular patients were enrolled, and 1567 drug-related problems (DRPs) were found, with reference to the inclusion and exclusion conditions.
Conclusion:In conclusion, population ageing and growth contribute to the global increase in CVD fatalities. Alcohol and tobacco use are linked to CVDs, with harmful effects observed at high consumption levels. Excessive alcohol and smoking increase blood pressure, cholesterol, and the risk of stroke and heart failure. However, moderate drinking poses minimal risks and may have some benefits. Efforts to reduce smoking and excessive drinking are essential for improving cardiovascular health and reducing CVD-related risks.